Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
The effect of cell therapy with NGF on CSF cholinergic biomarkers in ten patients with Alzheimer´s disease
- In: Poster Presentation
- At: Stockholm (Sweden) (2017)
- Type: Poster
- Poster code: P-A-087-Tuesday
- By: KARAMI, Azadeh (Karolinska Institutet, Department of Neurobiology, Care Sciences and Society (NVS), Stockholm, Sweden)
- Co-author(s): Azadeh Karami: Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden
Helga Eyjólfsdóttir: Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden
Swetha Vijayaraghavana: Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden
Ahmadul Kadir: Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden
Bengt Linderoth: Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden;Department of Neurosurgery, Karolinska University Hospital, Karolinska University Hospital, Stockholm, Sweden
Göran Lind: Department of Neurosurgery, Karolinska University Hospital, Karolinska University Hospital, Stockholm, Sweden;Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
Niels Andreasen: Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden;Department of Geriatric Medicine, Karolinska Institutet, Stockholm, Sweden
Anders Wall: Department of Radiology, Oncology and Radiation Sciences, Uppsala University, Uppsala, Sweden
Åke Seiger: Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden
Per Almqvist: Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden;Department of Neurosurgery, Karolinska University Hospital, Karolinska University Hospital, Stockholm, Sweden
Lars Wahlberg: Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden;, NsGene A/S, Ballerup, Denmark
Agneta Nordberg: Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden;Department of Geriatric Medicine, Karolinska Institutet, Stockholm, Sweden
Taher Darreh-Shori: Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden
Maria Eriksdotter: Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden;Department of Geriatric Medicine, Karolinska Institutet, Stockholm, Sweden - Abstract:
Backgrounds
Alzheimer’s disease (AD) is a progressive disease and the most common form of dementia with extensive loss of central cholinergic functions and a gradual decline in cognition and memory. Animal studies indicate that nerve growth factor (NGF) improves cholinergic functions, memory and cognitive behaviors. In addition, we have recently.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023